Trials / Completed
CompletedNCT01838213
Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients
Extended Spectrum Beta-lactamases - Treatment, Carriage, Environmental Dissemination And Population Epidemiology
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 760 (actual)
- Sponsor
- Vestre Viken Hospital Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This project aims at investigating the duration of human fecal carriage of bacteria harboring plasmid-borne resistance genes expressing Extended Spectrum beta-lactamases (ESBL), risk factors for infections with such bacteria and persistence, mobility and spread of ESBL in the environment and within households. It also aims to compare different methods of detecting ESBL carriage and treat patients with urinary tract infection caused by these bacteria.
Conditions
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2014-12-01
- First posted
- 2013-04-23
- Last updated
- 2015-11-23
- Results posted
- 2015-11-23
Source: ClinicalTrials.gov record NCT01838213. Inclusion in this directory is not an endorsement.